In the words of Drag Pharma's CEO, "Our team is driven by a passion to transform the pharmaceutical industry and make a meaningful difference in the lives of patients. We're excited to see the impact of our work and look forward to continuing to innovate and push the boundaries of what's possible."
"Drag Pharma" describes the strategic, operational, and regulatory inertia that incumbents (Big Pharma) use to protect market share, or the unintended consequences of bureaucracy that stifle innovation. It is the art of not moving quickly. drag pharma
